SLU7 and proximal spinal muscular atrophy: Likewise, the mechanism of antisense oligonucleotides (ASOs), which hold great promise as a therapeutic for SMA [10], can be better understood by a thorough understanding of the RNA binding proteins, such as the SR and hnRNP families of splicing factors, which may be competing for binding with ASOs [39].